Informations techniques
Exploitant
Winthrop médicaments (Groupe Sanofi Aventis)
Présentation
DILRENE LP 300 mg, gélule à libération prolongée
B/ 28 - (Code CIP : 331 991-4)
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
M5CJt7nSB62hKE48